Wren Therapeutics ^Company

Wren Therapeutics is a biopharmaceutical company based in Cambridge UK, focused on drug discovery and development for protein misfolding diseases, which include AlzheimerвАЩs and ParkinsonвАЩs diseases, type-2 diabetes, and many rare forms of amyloidosis. WrenвАЩs proprietary technology platform is built on new and fundamental understanding of the origins of these diseases and is based on decades of scientific research at the University of Cambridge and Lund University. Wren is using this platform to develop small molecule therapeutics for multiple protein misfolding diseases, including major neurological and rare disorders.